Research / CRS / Fundamental state Inspectable configuration
State dimensions Filing 0000017843-17-000050 General Corporate
Debt relative to revenue 15th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
33.66% · OPTIONAL · VALID
Capex intensity 46th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.48% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.19% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth 67th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
-0.87% · CORE · VALID
Inventory pressure 23th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.41% · OPTIONAL · VALID
Gross margin 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
15.82% · CORE · VALID
Operating margin 62th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
5.41% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.94% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 67th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.72% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 127.55%
Current 33.66%
Delta -93.90% Capex Intensity Increased
Previous 3.80%
Current 5.48%
Delta 1.68% Growth Decreased
Previous 3.79%
Current -0.87%
Delta -4.66% Inventory Pressure Decreased
Previous 151.67%
Current 38.41%
Delta -113.26% Margin Decreased
Previous 17.55%
Current 15.82%
Delta -1.73% Profitability Decreased
Previous 7.56%
Current 5.41%
Delta -2.15% Sbc Intensity Decreased
Previous 0.74%
Current 0.72%
Delta -0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.